Abstract
The article reports on the findings of a study which determined the capacity of rituximab to reduce the risk of disease progression on untreated patients with follicular lymphoma.
| Original language | English |
|---|---|
| Pages (from-to) | 309-309 |
| Number of pages | 1 |
| Journal | British Journal of Hospital Medicine |
| Volume | 71 |
| Issue number | 6 |
| Publication status | Published - Jun 2010 |